RxDoctor Payments Data

Tyler Nielsen

Family · Lone Tree, CONPI 1154056000

Payments from drug & device makers

$1,773in general payments, 2019–2025

Across 92 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$161
  • Astellas Pharma US Inc$156
  • Lilly USA, LLC$143
  • AbbVie$137
  • Bayer$123
  • Novo Nordisk$101
  • plus $951 from 21 others

What the payments were for

  • Food & beverage$1,773100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,773 in reported general payments places this provider in the 85th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$14,307
Medicare patients
81
Services billed
302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$34,616
EliquisApixaban13$14,558
MyrbetriqMirabegron12$12,198
JardianceEmpagliflozin13$7,595
ProgesteroneProgesterone, Micronized12$774
Levothyroxine Sodium82$750
Metformin Hcl ErMetformin Hcl17$636
Atorvastatin Calcium61$505
Gabapentin26$431
Ezetimibe29$322
Venlafaxine Hcl ErVenlafaxine Hcl12$216
Pantoprazole Sodium16$210
Pravastatin Sodium17$197
Losartan Potassium35$174
Oxybutynin Chloride ErOxybutynin Chloride22$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$101$34,61631 claims
PfizerEliquis$93$14,55813 claims
Astellas Pharma US IncMyrbetriq$156$12,19812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,182 family providers in Colorado.

Other family in Lone Tree

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →